Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 9/20 | 0.41 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.40 |
| ▸ | CDK2 | P24941 | 1/20 | 0.40 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.40 |
| ▸ | IRAK4 | Q9NWZ3 | 2/20 | 0.40 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | PARP15 | Q460N3 | 1/20 | 0.38 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19955027 | 0.98 | CCNA2 (0.42) | ACACBCCNA2CDK2CCNA1IRAK4 | |
| SCHEMBL18133480 | 0.94 | ACACB (0.45) | ACACB | |
| SCHEMBL19955139 | 0.84 | NFE2L2 (0.46) | ACACB | |
| SCHEMBL15215054 | 0.80 | ACACB (0.39) | ACACBCCNA2CDK2CCNA1 | |
| SCHEMBL16453454 | 0.80 | KDM4E (0.44) | CCNA2CDK2CCNA1IRAK4MAOA | |
| SCHEMBL19955136 | 0.79 | ACACB (0.43) | ACACB | |
| SCHEMBL16453504 | 0.78 | KDM4E (0.46) | CCNA2CDK2CCNA1MAOAMAOB | |
| SCHEMBL15129189 | 0.77 | LOX (0.39) | CCNA2CDK2CCNA1PARP10 | |
| SCHEMBL15129272 | 0.77 | CDK2 (0.38) | ACACBCCNA2CDK2CCNA1IRAK4 | |
| SCHEMBL16453457 | 0.77 | LOX (0.46) | CCNA2CDK2CCNA1IRAK4MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9914723-B2 | Small molecule inhibitors of Mcl-1 and uses thereof | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2018-03-13 | — | — | US | disclosed |